Literature DB >> 29686105

COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer.

Ken-Ichi Takayama1, Takashi Suzuki2, Tetsuya Fujimura3, Satoru Takahashi4, Satoshi Inoue5,6.   

Abstract

Androgen receptor (AR) signaling is essential for prostate cancer progression and acquiring resistance to hormone therapy. However, the molecular pathogenesis through AR activation has not been fully understood. We performed integrative transcriptomic analysis to compare the AR program in a castration-resistant prostate cancer (CRPC) model with that in their parental hormone-sensitive cells. We found that the gene cordon-bleu-like 1 (COBLL1) is highly induced by AR in CRPC model cells. The expression of COBLL1 that possesses an actin-binding domain is up-regulated in clinical prostate cancer tissues and is associated with a poor prognosis for prostate cancer patients. COBLL1 is involved in the cancer cell morphogenesis to a neuron-like cell shape observed in the CRPC model cells, promoting cell growth and migration. Moreover, nuclear COBLL1 interacts with AR to enhance complex formation with CDK1 and facilitates AR phosphorylation for genomic binding in CRPC model cells. Thus, our findings showed the mechanistic relevance of cordon-bleu proteins during the AR-mediated progression to CRPC.

Entities:  

Keywords:  CDK1; COBLL1; androgen receptor; cell morphology; prostate cancer

Mesh:

Substances:

Year:  2018        PMID: 29686105      PMCID: PMC5948986          DOI: 10.1073/pnas.1721957115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  The functions of the actin nucleator Cobl in cellular morphogenesis critically depend on syndapin I.

Authors:  Lukas Schwintzer; Nicole Koch; Rashmi Ahuja; Julia Grimm; Michael M Kessels; Britta Qualmann
Journal:  EMBO J       Date:  2011-07-01       Impact factor: 11.598

2.  Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.

Authors:  S H Han; S-H Kim; H-J Kim; Y Lee; S-Y Choi; G Park; D-H Kim; A Lee; J Kim; J-M Choi; Y Kim; K Myung; H Kim; D-W Kim
Journal:  Leukemia       Date:  2017-04-11       Impact factor: 11.528

3.  The actin nucleator Cordon-bleu is required for development of motile cilia in zebrafish.

Authors:  Andrew M Ravanelli; John Klingensmith
Journal:  Dev Biol       Date:  2010-12-01       Impact factor: 3.582

4.  Cordon-bleu is an actin nucleation factor and controls neuronal morphology.

Authors:  Rashmi Ahuja; Roser Pinyol; Nicole Reichenbach; Laura Custer; John Klingensmith; Michael M Kessels; Britta Qualmann
Journal:  Cell       Date:  2007-10-19       Impact factor: 41.582

Review 5.  Actin filament nucleation and elongation factors--structure-function relationships.

Authors:  Roberto Dominguez
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Nov-Dec       Impact factor: 8.250

6.  Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Authors:  Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan Yu; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

7.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

8.  Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer.

Authors:  Ken-Ichi Takayama; Kuniko Horie-Inoue; Shintaro Katayama; Takashi Suzuki; Shuichi Tsutsumi; Kazuhiro Ikeda; Tomohiko Urano; Tetsuya Fujimura; Kiyoshi Takagi; Satoru Takahashi; Yukio Homma; Yasuyoshi Ouchi; Hiroyuki Aburatani; Yoshihide Hayashizaki; Satoshi Inoue
Journal:  EMBO J       Date:  2013-05-03       Impact factor: 11.598

9.  The Actin Nucleator Cobl Is Controlled by Calcium and Calmodulin.

Authors:  Wenya Hou; Maryam Izadi; Sabine Nemitz; Natja Haag; Michael M Kessels; Britta Qualmann
Journal:  PLoS Biol       Date:  2015-09-03       Impact factor: 8.029

10.  Cordon Bleu serves as a platform at the basal region of microvilli, where it regulates microvillar length through its WH2 domains.

Authors:  Jessica Wayt; Anthony Bretscher
Journal:  Mol Biol Cell       Date:  2014-07-16       Impact factor: 4.138

View more
  7 in total

1.  GWAS of allometric body-shape indices in UK Biobank identifies loci suggesting associations with morphogenesis, organogenesis, adrenal cell renewal and cancer.

Authors:  Sofia Christakoudi; Evangelos Evangelou; Elio Riboli; Konstantinos K Tsilidis
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.996

2.  Androgen-responsive tripartite motif 36 enhances tumor-suppressive effect by regulating apoptosis-related pathway in prostate cancer.

Authors:  Naoki Kimura; Yuta Yamada; Ken-Ichi Takayama; Tetsuya Fujimura; Satoru Takahashi; Haruki Kume; Satoshi Inoue
Journal:  Cancer Sci       Date:  2018-10-30       Impact factor: 6.518

3.  The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair.

Authors:  Ayesha A Shafi; Chris M McNair; Jennifer J McCann; Mohammed Alshalalfa; Anton Shostak; Tesa M Severson; Yanyun Zhu; Andre Bergman; Nicolas Gordon; Amy C Mandigo; Saswati N Chand; Peter Gallagher; Emanuela Dylgjeri; Talya S Laufer; Irina A Vasilevskaya; Matthew J Schiewer; Michael Brunner; Felix Y Feng; Wilbert Zwart; Karen E Knudsen
Journal:  Nat Commun       Date:  2021-01-15       Impact factor: 14.919

Review 4.  Targeting phase separation on enhancers induced by transcription factor complex formations as a new strategy for treating drug-resistant cancers.

Authors:  Ken-Ichi Takayama; Satoshi Inoue
Journal:  Front Oncol       Date:  2022-10-03       Impact factor: 5.738

Review 5.  Epigenetic changes in fibroblasts drive cancer metabolism and differentiation.

Authors:  Rajeev Mishra; Subhash Haldar; Surabhi Suchanti; Neil A Bhowmick
Journal:  Endocr Relat Cancer       Date:  2019-12       Impact factor: 5.678

6.  Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition.

Authors:  Kaori Saito; Qi Zhang; Haeun Yang; Kotoko Yamatani; Tomohiko Ai; Vivian Ruvolo; Natalia Baran; Tianyu Cai; Helen Ma; Rodrigo Jacamo; Vinitha Kuruvilla; Junichi Imoto; Sonoko Kinjo; Kazuho Ikeo; Kaori Moriya; Koya Suzuki; Takashi Miida; Yong-Mi Kim; Christopher P Vellano; Michael Andreeff; Joseph R Marszalek; Yoko Tabe; Marina Konopleva
Journal:  Blood Adv       Date:  2021-10-26

7.  Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer.

Authors:  Ken-Ichi Takayama; Takeo Kosaka; Takashi Suzuki; Hiroshi Hongo; Mototsugu Oya; Tetsuya Fujimura; Yutaka Suzuki; Satoshi Inoue
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.